by Jen Peters | Jun 22, 2022 | Home News (Left), News, News-2022
News & Events News TriSalus Life Sciences Provides Update on Development of Immunotherapy Platform Approach for Liver and Pancreatic Tumors DENVER and CHICAGO, JUNE 22, 2022 – TriSalus Life Sciences®, an immunotherapy company on a mission to extend and improve the...
by Jen Peters | Jun 6, 2022 | Home News (Left), News, News-2022
News & Events News TriSalus Life Sciences to Present at the Society of Interventional Radiology’s 2022 Annual Scientific Meeting *** MEDIA ADVISORY *** BOSTON, June 6, 2022 – TriSalus Life Sciences®, an interventional immunotherapy company on a mission to extend and...
by Jen Peters | Jun 3, 2022 | Events, Home News (Left)
News & Events News TriSalus Life Sciences to Present at the Society of Interventional Radiology’s 2022 Annual Scientific Meeting *** MEDIA ADVISORY *** BOSTON, June 6, 2022 – TriSalus Life Sciences®, an interventional immunotherapy company on a mission to extend and...
by Jen Peters | May 10, 2022 | Home News (Right), News, News-2022
News & Events News TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma DENVER and CHICAGO, May 10, 2022...
Recent Comments